Vertex CEO Defends Salary After Company Is Slammed For Orkambi Pricing At UK Hearing
Executive Summary
Vertex CEO Jeff Leiden has defended his company’s approach to pricing, as well as his $17m salary, at a heated UK public hearing on access to cystic fibrosis drug Orkambi.